1. Home
  2. IRIX vs CING Comparison

IRIX vs CING Comparison

Compare IRIX & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • CING
  • Stock Information
  • Founded
  • IRIX 1989
  • CING 2012
  • Country
  • IRIX United States
  • CING United States
  • Employees
  • IRIX N/A
  • CING N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRIX Health Care
  • CING Health Care
  • Exchange
  • IRIX Nasdaq
  • CING Nasdaq
  • Market Cap
  • IRIX 16.5M
  • CING 17.3M
  • IPO Year
  • IRIX 1996
  • CING 2021
  • Fundamental
  • Price
  • IRIX $1.01
  • CING $4.35
  • Analyst Decision
  • IRIX
  • CING Strong Buy
  • Analyst Count
  • IRIX 0
  • CING 4
  • Target Price
  • IRIX N/A
  • CING $30.67
  • AVG Volume (30 Days)
  • IRIX 67.3K
  • CING 94.5K
  • Earning Date
  • IRIX 08-07-2025
  • CING 08-12-2025
  • Dividend Yield
  • IRIX N/A
  • CING N/A
  • EPS Growth
  • IRIX N/A
  • CING N/A
  • EPS
  • IRIX N/A
  • CING N/A
  • Revenue
  • IRIX $48,804,000.00
  • CING N/A
  • Revenue This Year
  • IRIX $9.61
  • CING N/A
  • Revenue Next Year
  • IRIX N/A
  • CING N/A
  • P/E Ratio
  • IRIX N/A
  • CING N/A
  • Revenue Growth
  • IRIX N/A
  • CING N/A
  • 52 Week Low
  • IRIX $0.78
  • CING $1.80
  • 52 Week High
  • IRIX $2.41
  • CING $20.83
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 61.37
  • CING 55.28
  • Support Level
  • IRIX $0.92
  • CING $4.26
  • Resistance Level
  • IRIX $1.01
  • CING $4.69
  • Average True Range (ATR)
  • IRIX 0.05
  • CING 0.22
  • MACD
  • IRIX 0.02
  • CING 0.02
  • Stochastic Oscillator
  • IRIX 100.00
  • CING 64.56

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: